We assessed the relationship between distance to clinic and progression through the HIV care cascade. We have two key findings. First, distance matters but only for women. Second, for women, distance affected linkage to care, but was not associated with later transitions in the care cascade. It is possible that distance is a less important barrier once people find out their HIV status, learn about treatment, and overcome the hurdle of their first clinic visit.
HIV testing is free in Malawi, but users may still incur costs that can deter or delay them accessing these services. We sought to identify and quantify these costs among HIV testing service clients in Malawi. We asked residents of communities participating in a cluster randomised trial investigating the impact of HIV self-testing about their past HIV testing experiences and the direct non-medical and indirect costs incurred to access HIV testing. We recruited 749 participants whose most recent HIV test was within the past 12 months.
Over the last three decades, a range of biomedical and behavioral approaches have dramatically reduced HIV incidence throughout the world and improved the quality and availability of life-saving treatment for those living with HIV. Yet HIV remains a major public health issue and the leading cause of adult death in sub-Saharan Africa.
AIDS 2018: Finding ways to break barriers and build bridges to improve HIV prevention, care, and treatment
Female, male, and transgender sex workers continue to have disproportionately high burdens of HIV infection in low-income, middle-income, and high-income countries in 2018. 4 years since our Lancet Series on HIV and sex work, our updated analysis of the global HIV burden among female sex workers shows that HIV prevalence is unacceptably high at 10·4% (95% CI 9·5–11·5) and is largely unchanged. Comprehensive epidemiological data on HIV and antiretroviral therapy (ART) coverage are scarce, particularly among transgender women.
HIV infection is now clinically manageable with antiretroviral therapy (ART). However, a significant number of people with HIV do not benefit from ART because of non-adherence. This study examined the use of adherence strategies and barriers to adherence among persons at substantial risk for developing resistant virus (less than 75% adherent).
An overview of this key structural barrier to an effective HIV response, giving definitions, tools and experiences from interventions.
Presented by Anne Stangl, Behavioral Scientist and Stigma Specialist, International Center for Research on Women, Washington, DC, 12 October 2011.
At AIDS 2016, the Department of State’s Office of the U.S. Global AIDS Coordinator and Health Diplomacy (S/GAC) announced the establishment of a Key Populations Investment Fund (KPIF) of US$100 million over five years. The KPIF aims to support the scale-up of key population led community approaches to enhance and expand quality HIV/AIDS services for key populations, and will address stigma, discrimination, and violence against key population groups.